Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
Cong Xue,1 Ying Tian,2 Jing Zhang,3 Yuanyuan Zhao,1 Jianhua Zhan,2 Wenfeng Fang,1 Li Zhang1 1Department of Medical Oncology, 2Department of Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, 3Departmen...
Main Authors: | Xue C, Tian Y, Zhang J, Zhao Y, Zhan J, Fang W, Zhang L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-bibf-1120-or-bibf-1120-plus-chemotherapy-on-nasopharyngeal-peer-reviewed-article-DDDT |
Similar Items
-
Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
by: Antoniu Sabina A
Published: (2012-11-01) -
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
by: Gori B, et al.
Published: (2011-11-01) -
Does Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?
by: Zohreh Sanaat, et al.
Published: (2014-09-01) -
Tumoral angiogenesis in both adrenal adenomas and nonadenomas: a promising computed tomography biomarker for diagnosis
by: Wang X, et al.
Published: (2016-03-01) -
High-Peak-Power Nanosecond 1120-nm Pulsed Laser Hybrid Pumped by a Self-Pulsed Ytterbium-Doped Fiber MOPA
by: Haibin Lu, et al.
Published: (2015-01-01)